{"cluster": 42, "subcluster": 4, "abstract_summ": "This cross-neutralizing antibody targets a communal epitope on these viruses and may offer potential for prevention and treatment of COVID-19.COVID\u201019 pandemic is an emerging new human disease, where no vaccines, or monoclonal antibodies (mAbs), or drugs are currently available for therapy.Here we report a human monoclonal antibody that neutralizes SARS-CoV-2 (and SARS-CoV).Here we report a human monoclonal antibody that neutralizes SARS-CoV-2 (and SARS-CoV) in cell culture.The emergence of the novel human coronavirus SARS-CoV-2 in Wuhan, China has caused a worldwide epidemic of respiratory disease (COVID-19).The emergence of the novel human coronavirus SARS-CoV-2 in Wuhan, China has caused a worldwide epidemic of respiratory disease (COVID-19).", "title_summ": "A human monoclonal antibody blocking SARS-CoV-2 infectionSARS-CoV-2 SPIKE PROTEIN: an optimal immunological target for vaccinesNeed for Speed: From Human SARS-CoV-2 Samples to Protective and Efficacious Antibodies in WeeksA human monoclonal antibody blocking SARS-CoV-2 infectionReflection on passive immunotherapy in those who need most: some novel strategic arguments for obtaining safer therapeutic plasma or autologous antibodies from recovered COVID \u201019 infected patients", "title_abstract_phrases": "This cross-neutralizing antibody targets a communal epitope on these viruses and may offer potential for prevention and treatment of COVID-19.Reflection on passive immunotherapy in those who need most: some novel strategic arguments for obtaining safer therapeutic plasma or autologous antibodies from recovered COVID \u201019 infected patientsCOVID\u201019 pandemic is an emerging new human disease, where no vaccines, or monoclonal antibodies (mAbs), or drugs are currently available for therapy.A human monoclonal antibody blocking SARS-CoV-2 infectionThe emergence of the novel human coronavirus SARS-CoV-2 in Wuhan, China has caused a worldwide epidemic of respiratory disease (COVID-19).A human monoclonal antibody blocking SARS-CoV-2 infectionThe emergence of the novel human coronavirus SARS-CoV-2 in Wuhan, China has caused a worldwide epidemic of respiratory disease (COVID-19).Here we report a human monoclonal antibody that neutralizes SARS-CoV-2 (and SARS-CoV).Here we report a human monoclonal antibody that neutralizes SARS-CoV-2 (and SARS-CoV) in cell culture."}